Cart
sales@molnova.com
N-Acetyl-L-arginine dihydrate
CAS No. 210545-23-6
N-Acetyl-L-arginine dihydrate( N-Ac-L-arg-OH )
Catalog No. M20060 CAS No. 210545-23-6
N-alpha-Acetylarginine is one of the guanidino compounds found elevated in the serum of a hemodialyzed renal insufficient (uremic) pediatric population.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 50MG | 28 | In Stock |
|
| 100MG | 39 | In Stock |
|
| 200MG | 56 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Acetyl-L-arginine dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-alpha-Acetylarginine is one of the guanidino compounds found elevated in the serum of a hemodialyzed renal insufficient (uremic) pediatric population.
-
DescriptionN-alpha-Acetylarginine is one of the guanidino compounds found elevated in the serum of a hemodialyzed renal insufficient (uremic) pediatric population.
-
In Vitro——
-
In Vivo——
-
SynonymsN-Ac-L-arg-OH
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number210545-23-6
-
Formula Weight252.27
-
Molecular FormulaC8H20N4O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO.O.CC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.De Deyn PP et al. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations. Nephron. 1995;69(4):411-7.
molnova catalog
related products
-
Vicinin 2
Vicinin 2 is a natural product of Vicia, Fabaceae. Vicinin 2 can be used as a reference standard.
-
Bruceantinol B
Bruceantinol B is a natural product for research related to life sciences.
-
pep2-AVKI
Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).
